Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders

BACKGROUND: Hyperphosphatemia in chronic kidney disease (CKD) patients is often treated with calcium carbonate (CaCO3) despite the fact that CaCO3 is associated with increased calcium load and potentially increased cardiovascular risk. Alternative treatments with noncalcium-based phosphate binders d...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, B. L., Soraya, A., Goh, A., Ang, K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169205/
https://www.ncbi.nlm.nih.gov/pubmed/30327732
http://dx.doi.org/10.1155/2018/2138528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169205/
https://www.ncbi.nlm.nih.gov/pubmed/30327732
http://dx.doi.org/10.1155/2018/2138528

Ejemplares similares